SC
EXAS

SummitTX Capital’s Exact Sciences EXAS Stock Holding History

SummitTX Capital’s Portfolio EXAS Stock Details EXAS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		– Sell
-81,889
Closed -$8.32M – 833
2025
Q4 		$8.32M Buy
81,889
+61,145
+295% +$4.91M 0.25% 98
2025
Q3 		$1.13M Buy
20,744
+14,669
+241% +$733K 0.05% 357
2025
Q2 		$323K Buy
+6,075
New +$309K 0.01% 597

Other funds holding EXAS

VanEck Associates
VanEck Associates New York $133B AUM 72.99% 1-Year Est. Return
Wealth Enhancement Advisory Services
Wealth Enhancement Advisory Services Plymouth, Minnesota $59.8B AUM 29.42% 1-Year Est. Return
PRS
Pinkerton Retirement Specialists Coeur D Alene, Idaho $1.1B AUM 30.57% 1-Year Est. Return
PWMAG
Pinnacle Wealth Management Advisory Group Red Bank, New Jersey $1.46B AUM 22.77% 1-Year Est. Return
IA
IFP Advisors Tampa, Florida $4.82B AUM 20.19% 1-Year Est. Return
HNB
Huntington National Bank Columbus, Ohio $18.1B AUM 24.69% 1-Year Est. Return

SummitTX Capital's EXAS Position: Q1 2026 in Review

SummitTX Capital sold out of Exact Sciences (EXAS) in Q1 2026, closing a stake of 81,889 shares — an estimated $8.32M sold.

SummitTX Capital first reported a position in EXAS in Q2 2025 and held it in 3 quarters. The position peaked at $8.32M in Q4 2025. 6 funds tracked by Wall St. Rank hold EXAS as of Q1 2026.

  • SummitTX Capital reported no remaining Exact Sciences position as of Q1 2026 after selling out during the quarter.
  • SummitTX Capital sold 81,889 Exact Sciences shares in Q1 2026, an estimated $8.32M.
  • SummitTX Capital first reported a position in Exact Sciences in Q2 2025 and held it in 3 quarters.
  • SummitTX Capital's Exact Sciences position peaked at $8.32M in Q4 2025.
  • 6 funds tracked by Wall St. Rank held Exact Sciences as of Q1 2026.

Based on SummitTX Capital's 13F filing for Q1 2026, filed 15 May 2026.